Vickie S Reed's Net Worth
$388 Thousand
Who is Vickie S Reed?
Vickie S Reed does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Mirati Therapeutics, Inc., Evoke Pharma Inc, and Adamis Pharmaceuticals Corp.
SEC CIK
Vickie S Reed's CIK is 0001405637
Past Insider Trading and Trends
2020 was Vickie S Reed's most active year for acquiring shares with 4 total transactions. Vickie S Reed's most active month to acquire stocks was the month of December. 2021 was Vickie S Reed's most active year for disposing of shares, totalling 3 transactions. Vickie S Reed's most active month to dispose stocks was the month of December. 2021 saw Vickie S Reed paying a total of $0.00 for 80,656 shares, this is the most they've acquired in one year. In 2022 Vickie S Reed cashed out on 1,636 shares for a total of $223,103.73, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Mirati Therapeutics, Inc. (MRTX) No price found
SVP, Chief Accounting Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +46.02% | 4.84K |
$120.48 | -$64,217.23 | 15.37K |
Jan 14 - Jan 18
| |||
Form 4
| -3.17% | -345.00 |
$135.94 | -$46,899.96 | 10.53K |
Jan 7
| |||
Form 4
| -6.52% | -758.00 |
$147.74 | -$111,986.54 | 10.87K |
Jan 4
| |||
Form 4
| +55.64% | 4.16K |
—
|
—
| 11.63K |
Jan 15
| |||
Form 4
| -9.44% | -779.00 |
$212.23 | -$165,325.15 | 7.47K |
Jan 6 - Jan 7
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
| +50.00% | 2.75K |
—
|
—
| 8.25K |
Jan 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Evoke Pharma Inc (EVOK) Snapshot price: $0.655
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Adamis Pharmaceuticals Corp (DMK) Snapshot price: $0.1665
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
| No matching records found | |||||||||